Table 2.

The protective effect of compounds 1–25 on BEAS-2B cell injury induced by LPS.

Group	Dose	Cell Viability
CON	---	1.000 ± 0.043 **
LPS	10 μg/mL	0.879 ± 0.065
DEX	1 μM	0.959 ± 0.017 **
1	10 μM	0.869 ± 0.046
2	10 μM	0.937 ± 0.039 *
3	10 μM	0.963 ± 0.034 **
4	10 μM	0.931 ± 0.016
5	10 μM	0.843 ± 0.006
6	10 μM	0.845 ± 0.022
7	10 μM	0.907 ± 0.030
8	10 μM	0.949 ± 0.041 **
9	10 μM	0.949 ± 0.021 **
10	10 μM	1.029 ± 0.062 **
11	10 μM	0.964 ± 0.034 **
12	10 μM	0.929 ± 0.013
13	10 μM	0.909 ± 0.028
14	10 μM	0.917 ± 0.012
15	10 μM	0.990 ± 0.021 **
16	10 μM	1.014 ± 0.036 **
17	10 μM	0.957 ± 0.034 **
18	10 μM	0.954 ± 0.064 **
19	10 μM	0.976 ± 0.054 **
20	10 μM	0.912 ± 0.026
21	10 μM	0.845 ± 0.022
22	10 μM	0.843 ± 0.006
23	10 μM	0.882 ± 0.015
24	10 μM	0.914 ± 0.009
25	10 μM	0.907 ± 0.030

* p < 0.05; ** p < 0.01 compared with the LPS group. Three independent experiments were performed, and the data were expressed as the mean ± SD.